Keyphrases
Autosomal Dominant Alzheimer's Disease
85%
Alzheimer's Disease
82%
Dominantly Inherited Alzheimer Network
49%
Mutation Carriers
42%
Symptom Onset
35%
Sporadic Alzheimer's Disease
26%
Autosomal Dominant
25%
Cerebrospinal Fluid
24%
Pittsburgh Compound B
23%
Alzheimer's Dementia
20%
Non-carriers
20%
Dominantly Inherited Alzheimer's Disease
20%
Clinical Dementia Rating
18%
Late-onset Alzheimer's Disease
17%
Functional Connectivity
15%
Age of Onset
14%
Familial Alzheimer's Disease
14%
Disease-causing mutations
13%
Alzheimer's Disease Biomarkers
13%
Clinical Trials
12%
Cognitively Normal
12%
Phosphorylated tau
11%
Disease Progression
11%
Neurodegeneration
11%
Alzheimer's Disease Pathology
10%
Cerebrospinal Fluid Biomarkers
10%
Preclinical Stage
10%
Cognitive Decline
10%
Aging
10%
Rate of Change
9%
Adult children
9%
Child Study
9%
Dementia
9%
Biomarker Changes
9%
Imaging Biomarkers
9%
Driving Performance
9%
Network Studies
8%
Age-related
8%
Amyloid Burden
8%
Amyloid Imaging
8%
P-tau181
8%
Default Mode Network
8%
Neuronal Injury
8%
Serum Neurofilament
8%
Road Test
8%
White Matter Hyperintensities
8%
Positron Emission Tomography
7%
Asymptomatic mutation Carriers
7%
Neurofilament Light (NF-L)
7%
Amyloid Deposition
7%
Medicine and Dentistry
Alzheimer's Disease
100%
Autosomal Dominant Inheritance
65%
Amyloid Protein
32%
Biological Marker
21%
Cerebrospinal Fluid
20%
Pittsburgh Compound B
20%
Tau
16%
Polyethylene Terephthalate
12%
Clinical Dementia Rating
12%
Familial Alzheimer's Disease
12%
Onset Age
10%
Positron Emission Tomography
9%
Observational Study
9%
Magnetic Resonance Imaging
8%
Diseases
8%
Functional Connectivity
8%
Behavioral Change
5%
Neuropathology
5%
Cerebral Atrophy
5%
